These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7865351)

  • 1. Cytokines in the treatment of fungal infections.
    Kullberg BJ; van 't Wout JW
    Biotherapy; 1994; 7(3-4):195-210. PubMed ID: 7865351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy.
    Roilides E; Lamaignere CG; Farmaki E
    Int J Infect Dis; 2002 Sep; 6(3):154-63. PubMed ID: 12718828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in immunotherapy of fungal infections.
    Kullberg BJ
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):51-5. PubMed ID: 9063674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of immunocompromised patients with evidence of an invasive mycosis.
    Walsh TJ
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to fungal infections.
    Shoham S; Levitz SM
    Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy.
    Clemons KV; Stevens DA
    Semin Respir Infect; 2001 Mar; 16(1):60-6. PubMed ID: 11309713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
    Roilides E; Dignani MC; Anaissie EJ; Rex JH
    Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and fungal infections.
    Antachopoulos C; Roilides E
    Br J Haematol; 2005 Jun; 129(5):583-96. PubMed ID: 15916680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal vaccines, mechanism of actions and immunology: A comprehensive review.
    Nami S; Mohammadi R; Vakili M; Khezripour K; Mirzaei H; Morovati H
    Biomed Pharmacother; 2019 Jan; 109():333-344. PubMed ID: 30399567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and mycoses.
    Stevens DA; Walsh TJ; Bistoni F; Cenci E; Clemons KV; Del Sero G; Fè d'Ostiani C; Kullberg BJ; Mencacci A; Roilides E; Romani L
    Med Mycol; 1998; 36 Suppl 1():174-82. PubMed ID: 9988506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy against invasive mold infections.
    Antachopoulos C; Katragkou A; Roilides E
    Immunotherapy; 2012 Jan; 4(1):107-20. PubMed ID: 22150004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment: antifungal drugs with antibodies, cytokines or drugs.
    Stevens DA; Kullberg BJ; Brummer E; Casadevall A; Netea MG; Sugar AM
    Med Mycol; 2000; 38 Suppl 1():305-15. PubMed ID: 11204158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokines in the treatment of bacterial and fungal infections.
    Netea MG; Kullberg BJ; Van der Meer JW
    BioDrugs; 2004; 18(1):9-22. PubMed ID: 14733604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals.
    van der Meer JW; Vogels MT; Kullberg BJ
    Biotherapy; 1994; 7(3-4):161-7. PubMed ID: 7865347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunotherapeutic strategies for invasive fungal disease.
    van Spriel AB
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Sep; 3(3):209-17. PubMed ID: 12871039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor and other cytokines in antifungal therapy.
    Roilides E; Farmaki E
    Clin Microbiol Infect; 2001; 7 Suppl 2():62-7. PubMed ID: 11525220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
    Walsh TJ; Lee JW; Roilides E; Pizzo PA
    Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.